Notice of Registration - 2012
[Federal Register Volume 77, Number 123 (Tuesday, June 26, 2012)]
[Notices]
[Pages 38085-38086]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-15607]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration;
Cayman Chemical Company
By Notice dated March 8, 2012, and published in the Federal
Register on March 20, 2012, 77 FR 16263, Cayman Chemical Company, 1180
East Ellsworth Road, Ann Arbor, Michigan 48108, made application to the
Drug Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the following basic classes of controlled substances:
| Drug |
Schedule |
| 4-Methyl-N-methylcathinone (1248) |
I |
| Gamma Hydroxybutyric Acid (2010) |
I |
| Mescaline (7381) |
I |
| N-Benzylpiperazine (7493) |
I |
| 3,4-Methylenedioxyprovalerone (7535) |
I |
| 3,4-Methylenedioxy-N-methylcathinone (7540) |
I |
The company plans to manufacture the above listed controlled
substances to supply these materials to the research and forensics
community for drug testing and analysis.
[[Page 38086]]
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Cayman Chemical Company to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Cayman Chemical Company to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history.
Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR
Sec. 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic classes of controlled substances listed.
Dated: June 18, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-15607 Filed 6-25-12; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |
